// App-Quantinova.ai

2610 : A New Pathogenic Role Of BAFF As a Critical Mediator Of Skin and Lung Fibrosis In Experimental Bleomycin-Induced Pulmonary Fibrosis, Systemic Sclerosis and Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • Antoine Francois

Principal Investigators

  • Pascal Schneider

  • Anne Davidson

  • Bernhard Ryffel

  • Siamak Bahram

  • Philippe Georgel

  • Jean Sibilia

  • Isabelle Couillin

  • Emmanuel Chatelus

  • Jerome Avouac

  • Yannick Allanore

  • Berengere Villeret

  • Aurelie Gombault

  • Pamela Gasse

  • Sylvain March

Medical Centers

  • Francois Rabelais University, National institute of the health and the medical research, Tours, France

  • UMR, Molecular Immunology, University and CNRS, b rue de la Ferollerie, Orleans, France

  • Strasbourg University, Strasbourg, France

  • Rheumatology, CHU Hautepierre, Strasbourg, France,

  • Federation of Translational Medicine of Strasbourg FMTS, Immunorhumatology Molecular, Strasbourg, France

  • Paris Descartes University, Radiology B department, Cochin Hospital, Paris, France

  • Molecular Immunology and Embryology, University of Orleans and National Center for Scientific Research, Orleans, France

  • Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, NY

  • Department of Urology, Strasbourg University Hospital, Strasbourg, France

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Idiopathic pulmonary fibrosis

  • Scleroderma

Biomarkers

  • Interleukin 17A

Drug/Treatment

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved